AA
ARLZ

Ancora Advisors’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Ancora Advisors’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-8,376
Closed – – 1370
2018
Q3 		$0 Buy
+8,376
New +$2.14K ﹤0.01% 1377
2017
Q4 		– Sell
-56,331
Closed – – 721
2017
Q3 		$0 Sell
56,331
-21,184
-27% -$28.4K ﹤0.01% 720
2017
Q2 		$105K Sell
77,515
-88,520
-53% -$128K 0.01% 610
2017
Q1 		$355K Buy
166,035
+69,310
+72% +$260K 0.02% 478
2016
Q4 		$426K Sell
96,725
-133,634
-58% -$634K 0.03% 430
2016
Q3 		$1.12M Sell
230,359
-16,324
-7% -$74.4K 0.11% 211
2016
Q2 		$814K Buy
246,683
+230,060
+1,384% +$868K 0.09% 231
2016
Q1 		$59K Buy
+16,623
New +$85.7K 0.01% 482

Ancora Advisors's ARLZ Position: Q4 2018 in Review

Ancora Advisors sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q4 2018, closing a stake of 8,376 shares.

Ancora Advisors first reported a position in ARLZ in Q1 2016 and held it in 8 quarters. The position peaked at $1.12M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARLZ as of Q4 2018.

  • Ancora Advisors reported no remaining Aralez Pharmaceuticals Inc. position as of Q4 2018 after selling out during the quarter.
  • Ancora Advisors sold 8,376 Aralez Pharmaceuticals Inc. shares in Q4 2018.
  • Ancora Advisors first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 8 quarters.
  • Ancora Advisors's Aralez Pharmaceuticals Inc. position peaked at $1.12M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q4 2018.

Based on Ancora Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.